Evidence map›Paper›PMID 39875449›Full record

ArticleScientific reports2025

Direct collaboration between hospitals and NGOs, an essential tool to reinforce linkage to care in people living with HIV.

Teresa Aldámiz-Echevarria, Chiara Fanciulli, Mónica Lopez, Leire Perez, Francisco Tejerina, David Sanchez, Blanca Lodeiros, Juan Carlos López, Juan Berenguer, Jose Maria Bellon and 15 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Teresa Aldámiz-EchevarriaServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain. teresaldamiz@yahoo.es.
Chiara FanciulliServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.
Mónica LopezDepartment of Social Workers, Gregorio Marañón General University Hospital, Madrid, Spain.
Leire PerezServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.
Francisco TejerinaServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.
David SanchezServicio de Medicina Interna, Gregorio Marañón General University Hospital, Madrid, Spain.
Blanca LodeirosServicio de Medicina Interna, Gregorio Marañón General University Hospital, Madrid, Spain.
Juan Carlos LópezServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.
Juan BerenguerInstituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Jose Maria BellonInstituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Maria FerrisServicio de Farmacología Clínica, Gregorio Marañón General University Hospital, Madrid, Spain.
Mario BlazquezCogam, NGO, Madrid, Spain.
Almudena CalvoCogam, NGO, Madrid, Spain.
Mario DomeneCogam, NGO, Madrid, Spain.
Oswaldo VegasCogam, NGO, Madrid, Spain.
Carmen RodriguezServicio de Farmacología Clínica, Gregorio Marañón General University Hospital, Madrid, Spain.
Patricia MuñozServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.
Paloma GijonServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.
Pedro MontillaServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.
Elena BermudezServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.
Maricela ValerioServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.
Roberto AlonsoServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.
Belen PadillaServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.
Critina VentimillaServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.
Cristina DiezServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Calle Doctor Esquerdo, 46, 28007, Madrid, Spain.

Funding

Gilead Grants, project number 14855
6 · The paper itself

Abstract

With the aim of improving access and engagement to healthcare in people living with HIV (PLHIV), in 2022 Gregorio Marañón Hospital and the NGO COGAM developed a circuit for recruitment and referral to hospital. Program targeted PLHIV who were neither receiving antiretroviral treatment (ART) nor on medical follow-up (FU); but also, individuals at risk who underwent screening tests at the NGO and, if positive, were referred for confirmation. The result was an increase in annual new PLHIV seen in hospital by reaching a population who were, essentially, young men (94% male, median age 30 years), migrants (95%) with recent diagnosis of HIV (median 5 years) and who were recently arrived in Spain (median 5 months). Most of them hadn´t healthcare coverage (78%). In multivariate analysis, that included all PLHIV seen for the first time in the ID Unit between 2019 and 2022, lack of healthcare coverage was the only independent predictor of lost to FU that reached statistical significance (HR 5.19, CI 2.76-9.47). Furthermore, time from HIV diagnosis to ART initiating was shortened from 14 to 6 days without affecting linkage to care. Our conclusion is that collaboration with NGOs reinforce diagnosis, FU, and adherence to ART for PLHIV.

Indexed as

HIV InfectionsHospitalsOrganizationsAdultFemaleHealth Services AccessibilityHumansMaleMiddle AgedSpainAccess to antiretroviral treatmentHIVLinkage-to-careMigrantsNGO

Identifiers

PMID39875449
PMCPMC11775109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.